Enjoy complimentary customisation on priority with our Enterprise License!
The US point-of-care testing (POCT) market size is forecast to increase by USD 10.22 billion at a CAGR of 9.45% between 2023 and 2028. The market is experiencing significant growth due to several key factors. The rising prevalence of chronic diseases, such as diabetes and cardiovascular diseases, has led to an increased demand for quick and accurate diagnostic tests at the point of care. Technological advancements in POCT devices, including miniaturization, wireless connectivity, and automation, are enabling faster and more precise testing, making them increasingly popular among healthcare providers and patients. Additionally, stringent regulation policies on POCT devices ensure their safety and efficacy, instilling confidence in their use and driving market growth. These trends are expected to continue, making the POCT market in the US an attractive investment opportunity for manufacturers and suppliers.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.